On December 9 2025 Racura Oncology Ltd ("Racura", ASX:RAC) reported following shareholder approval at the Company’s 2025 Annual General Meeting held on Monday, 24 November 2025, the name of the company will change from Race Oncology Limited to Racura Oncology Ltd. This change has been recorded by the Australian Securities and Investments Commission (ASIC) with effect from 5 December 2025. The ASX will implement the Company’s change of name from the commencement of trading on Wednesday, 10 December 2025. There is no change to the Company’s ASX listing code "RAC"

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

(Press release, Racura Oncology, DEC 9, 2025, View Source [SID1234665410])